Zobrazeno 1 - 4
of 4
pro vyhledávání: '"W. K.Alfred Yung"'
Autor:
Joon H. Uhm, W. K.Alfred Yung
Publikováno v:
CNS Drugs. 10:11-24
The retinoids and type I interferons constitute the 2 principal classes of biological response modifiers (BRMs) that have demonstrated activity in the treatment of malignant cerebral tumours, and are associated with fewer of the adverse effects induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46d9f4d183641674afb99a76a60ef09e
https://doi.org/10.2165/00023210-199810010-00002
https://doi.org/10.2165/00023210-199810010-00002
Autor:
Carol J. Wikstrand, Roger J. Packer, Anthony E. Pegg, Lawrence E. Kun, W. K.Alfred Yung, Elizabeth A. Grimm, Michael D. Walker, Dennis F. Deen, Laurence J. Marton, John R. Fike, Victor A. Levin, Herman D. Suit, Mark L. Rosenblum, Albert J. Wong, Charles B. Wilson, Mark A. Israel, Andrew Chiarodo
Publikováno v:
Journal of Neuro-Oncology. 16:243-272
Proceedings of the 9th International Conference on Brain Tumor Research and Therapy: 1. Introduction; 2. Surgery; 3. Radiation therapy; 4. Chemotherapy; 5. Immunotherapy; 6. Growth-regulatory alterations; 7. Molecular genetics; 8. Brain tumor invasio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24aef8171c604f5e014b940665b2c249
https://doi.org/10.1007/bf01057041
https://doi.org/10.1007/bf01057041
Autor:
Niramol Savaraj, ya Yen Lee, Sidney Wallace, Lynn G. Feun, C. Charnsangavej, Rosa A. Tang, W. k.Alfred Yung
Publikováno v:
Cancer Drug Delivery. 3:147-156
Intracarotid BCNU (100 mg/m2) and cisplatin (60 mg/m2) were administered to 36 patients with malignant brain tumors recurrent or progressive after cranial irradiation. Courses of therapy were repeated at 4-6 week intervals. Of 23 evaluable patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af5334e8ad64a1aeb1c224f8fc9a89e
https://doi.org/10.1089/cdd.1986.3.147
https://doi.org/10.1089/cdd.1986.3.147
Autor:
William S. Velasquez, Maria A Rodriguez, Fredrick B. Hagemeister, W. k.Alfred Yung, John R. Redman, P. McLaughlin, Fernando Cabanillas
Publikováno v:
JNCI Journal of the National Cancer Institute. 80:1408-1412
Ten patients with parenchymal CNS lymphoma received combination chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin (DHAP), and additional therapy according to clinical circumstances. Two of four patients with primary CNS lymphoma ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3fc5c02c29920d244314c94f404c83
https://doi.org/10.1093/jnci/80.17.1408
https://doi.org/10.1093/jnci/80.17.1408